These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31763953)

  • 1. Campylobacteriosis in the Nordic countries from 2000 to 2015: Trends in time and space.
    Kuhn KG; Nygård KM; Löfdahl M; Trönnberg L; Rimhanen-Finne R; Sunde LS; Guzman-Herrador B; Ethelberg S
    Scand J Public Health; 2020 Dec; 48(8):862-869. PubMed ID: 31763953
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of campylobacteriosis in Denmark 2000-2015.
    Kuhn KG; Nielsen EM; Mølbak K; Ethelberg S
    Zoonoses Public Health; 2018 Feb; 65(1):59-66. PubMed ID: 28597535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Campylobacteriosis rates show age-related static bimodal and seasonality trends.
    Nelson W; Harris B
    N Z Med J; 2011 Jun; 124(1337):33-9. PubMed ID: 21946876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of campylobacteriosis in Germany - insights from 10 years of surveillance.
    Schielke A; Rosner BM; Stark K
    BMC Infect Dis; 2014 Jan; 14():30. PubMed ID: 24422983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of Campylobacteriosis in Castile and Leon, Spain,during the period 2008-2015].
    Berradre-Sáenz B; Yáñez-Ortega JL; García-Sánchez L; Melero-Gil B; Rovira-Carballido J; Carramiñana-Martínez I; Tejero-Encinas S; Ruiz-Sopeña C; Fernández-Arribas S
    Rev Esp Salud Publica; 2017 Mar; 91():. PubMed ID: 28356551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Campylobacter infections in Ireland 2004-2016: What has changed?
    O'Connor L; McKeown P; Barrasa A; Garvey P
    Zoonoses Public Health; 2020 Jun; 67(4):362-369. PubMed ID: 32144864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Campylobacter incidence in broilers and humans in six European countries, 1997-2007.
    Jore S; Viljugrein H; Brun E; Heier BT; Borck B; Ethelberg S; Hakkinen M; Kuusi M; Reiersen J; Hansson I; Engvall EO; Løfdahl M; Wagenaar JA; van Pelt W; Hofshagen M
    Prev Vet Med; 2010 Jan; 93(1):33-41. PubMed ID: 19837471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional risks and seasonality in travel-associated campylobacteriosis.
    Ekdahl K; Andersson Y
    BMC Infect Dis; 2004 Nov; 4(1):54. PubMed ID: 15569393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse trends of Campylobacter and Salmonella in Swiss surveillance data, 1988-2013.
    Schmutz C; Mäusezahl D; Jost M; Baumgartner A; Mäusezahl-Feuz M
    Euro Surveill; 2016; 21(6):. PubMed ID: 26898102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
    Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
    Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic.
    Hjalgrim H; Melbye M; Pukkala E; Langmark F; Frisch M; Dictor M; Ekbom A
    Br J Cancer; 1996 Nov; 74(9):1499-502. PubMed ID: 8912552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based surveillance study of Campylobacter infections in Finland.
    Nakari UM; Huovinen E; Kuusi M; Siitonen A
    Epidemiol Infect; 2010 Dec; 138(12):1712-8. PubMed ID: 20307339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends of positivity rates from foodborne pathogen testing in Switzerland, 2003 to 2012.
    Bless PJ; Schmutz C; Sartori K; Mäusezahl D
    Swiss Med Wkly; 2017; 147():w14569. PubMed ID: 29282700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recurrent campylobacteriosis epidemic over Christmas and New Year in European countries, 2006-2014.
    Bless PJ; Schmutz C; Mäusezahl D
    BMC Res Notes; 2017 Jul; 10(1):266. PubMed ID: 28693589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence trend and risk factors for campylobacter infections in humans in Norway.
    Sandberg M; Nygård K; Meldal H; Valle PS; Kruse H; Skjerve E
    BMC Public Health; 2006 Jul; 6():179. PubMed ID: 16827925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacteriosis in Poland in 2015 and 2016.
    Radziszewski F; Kucharczyk B; Sadkowska-Todys M
    Przegl Epidemiol; 2018; 72(4):399-405. PubMed ID: 30808866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacteriosis in Poland in 2012.
    Sadkowska-Todys M; Kucharczyk B
    Przegl Epidemiol; 2014; 68(2):239-41, 349-51. PubMed ID: 25135507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spatial and temporal determinants of campylobacteriosis notifications in New Zealand, 2001-2007.
    Spencer SE; Marshall J; Pirie R; Campbell D; Baker MG; French NP
    Epidemiol Infect; 2012 Sep; 140(9):1663-77. PubMed ID: 22050713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Hodgkin's disease in Nordic countries.
    Hjalgrim H; Askling J; Pukkala E; Hansen S; Munksgaard L; Frisch M
    Lancet; 2001 Jul; 358(9278):297-8. PubMed ID: 11498219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A six-year epidemiological surveillance study in Split-Dalmatia County, Croatia: urban versus rural differences in human campylobacteriosis incidence.
    Carev M; Tonkić M; Boban N
    Int J Environ Health Res; 2018 Aug; 28(4):407-418. PubMed ID: 29869522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.